The impact on oncology of the interaction of radiation therapy and radiobiology

Clinical and Translational Oncology

Volumn 8, Issue 2, 2006, Pages 83-93

  Muriel, Vicente Pedraza ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Biologically effective dose; Cell killing; Conformal therapy; Dose per fraction; Reirradiation; Tumour control; Tumour response

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; OXYGEN;

CANCER CELL; CANCER CONTROL; CANCER RADIOTHERAPY; CELL DEATH; CELL HYPOXIA; CELL KILLING; CELL SURVIVAL; DNA STRAND BREAKAGE; HUMAN; LIP CANCER; MALIGNANT NEOPLASTIC DISEASE; MULTIMODALITY CANCER THERAPY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOBIOLOGY; RADIOSENSITIVITY; REVIEW; SKIN CANCER; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR REGRESSION;

EID: 49749114364     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-006-0163-0     Document Type: Review

References (50)

1. Puck TT, Markus PJ. Action of X-rays on mammalian cells. J Exp Med. 1956;103: 653-66.
2. Elkind MM, Sutton H. X-ray damage and recovery in mammalian cells in culture. Nature. 1959;184:1293-5.
3. Hewitt HB, Wilson CW. A survival curve for mammalian leukaemia cells irradiation in vivo. Br J Cancer. 1959;13:69-75.
4. Till JE, McCulloch AE. Repair processes in irradiated mouse hematopoietic tissue. Ann NY Acad Sci. 1964;114:15-25.
5. Fowler JF, Stern BE. Dose time relationships in radiotherapy and the validity of cell survival curve models. Br J Radiol. 1963;56:335-443.
6. Hermens AF, Barendsen GW. Changes of cell proliferation characteristics in a rat rhabdomyosarcoma before and after X-irradiation. Eur J Cancer. 1969;5:173-89.
7. Alper T. Cellular Radiobiology. London: London University Press; 1979.
8. Elkind MM, Whitmore GF. The Radiobiology of Cultured Mammalian Cells. New York: Gordon & Breach; 1969.
9. Ward JF. DNA damage produced by ionising radiation in mammalian cells: Identities, mechanisms of formation and repairability. Prog Nucl Acids Res Mol Biol. 1988;55:95-125.
10. Hall EJ, Cox JD. Physical and Biological Basis of Radition Therapy. In Radiation Oncology, Rationale, Techniques, Results. Cox JD, Kian Ang K, editors. St. Louis: Mosby; 2003, p. 3-62.
11. McBride WH, Withers HB. Biologic Basis of Radiation Therapy. In: Principles and Practice of Radiation Oncology. Pérez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK, editors. Philadelphia: Lippincott Williams Wilkins; 2004, p. 96-136.
12. Lea DE. Action of Radiation on Living Cells. Second Edition. Cambridge: Cambridge University Press; 1955.
13. Dutreix J, Wambersie A, Bounik C. Cellular recovery in human skin reactions: Applications to dose, fraction number and overall time relationship in radiotherapy. Eur J Cancer. 1973;9:159-67.
14. Fletcher GH. Oncology, Radiation Therapy and Radiobiology. Doctor Honoris Causa Lecture. Granada: Granada University Press; 1981, p. 15-29.
15. Pedraza V. Dose-time relationships in fractionated radiotherapy for cancer. Rev Oncol. 2005;5(1):49-54.
16. Withers HR: The four R's of Radiotherapy. In Advances in Radiation Biology. Lett JT, Adler H, editors. New York: Academic Press; 1975, p. 241-5.
17. Withers HR, Mc Bride WH. Radiation effects on normal tissues. Front Radiat Ther Onco, 1999;32:1-8.
18. Pedraza V. The biological basis of fractionation in radiotherapy. Rev Oncol. 2002;4 (3):161-5.
19. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27:131-46.
20. Pedraza V, Guerrero Tejada R, Luna del Castillo JD. Time-dose response relationships in postoperatively irradiated patients with head and neck squamous cell carcinomas. Radiother Oncol. 2001;60: 137-45.
21. Suit HD, Lindberg RD, Fletcher GH. Prognostic significance of extent of tumor regression at completion of radiation therapy. Radiology. 1965;4:1100-9.
22. Withers HR, Taylor JMG, Maciejeswki B, Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys. 1988;14:751-9.
23. Read J. The effect of ionizing radiation on the broad bean root. X. The dependence of the x-ray sensitivity of dissolved oxygen. Br J Radiol. 1952;25:89-99.
24. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and possible implications for radiotherapy. Br J Cancer. 1955;9:539-49.
25. Vaupel P, Schlenger K, Hoeckel M. Blood flow and tissue oxygenation of human tumors: An update. Adv Exp Med Biol. 1992;517:139-46.
26. Hockel M, Schlenger K, Aral B, Mitze M, Schaffe U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Radial Res. 1996;56:4506-15.
27. MacKillop WJ, Bates JHT, O'Sullivan MB, Withers HR. The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys. 1996;34:243-50.
28. Withers HR, Suwinski R. Radiation dose-response for subclinical metastases. Semin Radiat Oncol, 1998;8(3):224-8.
29. Withers HR. Radiation biology and treatment options in radiation oncology. Cancer Res. 1999;59:1676-84.
30. Strandqvist M. Studien uber die kumulative wirkung der roentgenstrahlen bei fractionierung. Acta Radiol (Stockholm). 1944;55 Suppl 1:1-293.
31. Hall EJ. Time, Dose and Fractionation in Radiotherapy. In: Radiobiology for the Radiologist. Fifth Edition. Philadelphia: Lippincott Williams Wilkins: 2000. p. 397-418.
32. Withers HR. Biological basis for altered fractionation schedules. Cancer. 1985;55: 2086-95.
33. Peters LJ, Withers HR. Applying radiobiological principles to combining modality treatment for head and neck cancer. The time factor. Int J Radiat Oncol Biol Phys. 1997;59:831-6.
34. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62:679-94.
35. Fowler JF, Harari P. Conformation of improved local-regiocal control with altered fractionation in head and neck cancer. Int J Radiat Oncol Biol Phys. 2000;48:5-6.
36. Withers HR, Peters LJ. Transmutability of dose and time. Commentary on the first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:1-2.
37. Williams MV, Denekamp J, Fowler JF. A review of α/β ratios for experimental tumors. Int J Radiat, Oncol Biol Phys. 1985; 11:87-96.
38. Horiot JC, LeFur FR, Nguyen T, Chenal C, Schraub S, Alfonsi S, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma. Final analysis of a randomised trial of the EORTC cooperative group of radiotherapy. Radiother Oncol. 1992;25:251-41.
39. Withers HR, Peters LJ, Taylor JMG, Owen JB, Morrison WH, Schultheiss TE, et al. Local control of carcinoma of the tonsil by radiation therapy. An analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys. 1995;55:549-62.
40. Peters LJ, Ang KK, Thames HD. Altered fractionation schedules. In: Principles and Practice of Radiation Oncology. Pérez, CA, Brady LH, editors. Philadelphia: JB Lippincott; 1992. p. 97-115.
41. Withers HR. Biological aspects of conformal therapy. Acta Oncol. 2000;39:569-77.
42. Haustermans K, Withers HR. The biologial basis of fractionation. Rays. 2004;29: 231-6.
43. Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 1999;43:1095-101.
44. Nieder C, Milas L, Ang KK. Tissue tolerance to reirradiation. Semin Radiat Oncol. 2000;10(3):200-9.
45. Bauman GS, Sneed PK, Wara WM, Stalpers LJA, Chang SM, McDermott MW, et al. Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys. 1996;36:433-41.
46. Nieder C, Grosu AL, Andratschke NH, Molls M. Proposal of human spinal cord irradiation dose based on collection of data from 40 patients. Int J Radiat Oncol Biol Phys. 2005;61:851-5.
47. Ruifrok ACC, Leiboer BJ, van der Kogel AJ. Fractionation sensitivity of the rat cervical spinal cord during radiation retreatment. Radiother Oncol. 1992;25:295-300.
48. Ang KK, Jiang JL, Feng Y, shephens LC, Tucker SL, Price RE. Extent and kinetics of recovery of occult spinal cord injury. Int J Radiat Oncol Biol Phys. 2001;50: 1013-20.
49. Nieder C, Nestle U, Niewald M, Walter K, Schnabel K. Hyperfractionated reirradiation for malignant glioma. Front Radiant Ther Oncol. 1999;53:150-7.
50. Stewart FA, Oussoren Y, van Tinteren H, Bentzen SM. Loss of reirradiation tolerance in the kidney with increasing time after single or fractionated partial tolerance doses. Int J Radiat Oncol Biol Phys. 1994;66:169-79.